BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23178420)

  • 1. Lymphopenia as a novel marker of Clostridium difficile infection recurrence.
    Lavergne V; Beauséjour Y; Pichette G; Ghannoum M; Su SH
    J Infect; 2013 Feb; 66(2):129-35. PubMed ID: 23178420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis to assess risk factors for recurrent Clostridium difficile infection.
    Garey KW; Sethi S; Yadav Y; DuPont HL
    J Hosp Infect; 2008 Dec; 70(4):298-304. PubMed ID: 18951661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case-control study of community-associated Clostridium difficile infection.
    Wilcox MH; Mooney L; Bendall R; Settle CD; Fawley WN
    J Antimicrob Chemother; 2008 Aug; 62(2):388-96. PubMed ID: 18434341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology, diagnosis and treatment of Clostridium difficile infection.
    Bassetti M; Villa G; Pecori D; Arzese A; Wilcox M
    Expert Rev Anti Infect Ther; 2012 Dec; 10(12):1405-23. PubMed ID: 23253319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can we identify patients at high risk of recurrent Clostridium difficile infection?
    Kelly CP
    Clin Microbiol Infect; 2012 Dec; 18 Suppl 6():21-7. PubMed ID: 23121551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibiotics.
    Garey KW; Dao-Tran TK; Jiang ZD; Price MP; Gentry LO; Dupont HL
    J Hosp Infect; 2008 Oct; 70(2):142-7. PubMed ID: 18723249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of polymerase chain reaction-diagnosed Clostridium difficile in a large high-risk cohort, 2011-2012.
    Tartof SY; Yu KC; Wei R; Tseng HF; Jacobsen SJ; Rieg GK
    Mayo Clin Proc; 2014 Sep; 89(9):1229-38. PubMed ID: 25064782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolution of urban C. difficile infection (CDI): CDI in 2009-2011 is less severe and has better outcomes than CDI in 2006-2008.
    Feuerstadt P; Das R; Brandt LJ
    Am J Gastroenterol; 2014 Aug; 109(8):1265-76. PubMed ID: 25001255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of Clostridium difficile infection after perioperative antibacterial prophylaxis before and during an outbreak of infection due to a hypervirulent strain.
    Carignan A; Allard C; Pépin J; Cossette B; Nault V; Valiquette L
    Clin Infect Dis; 2008 Jun; 46(12):1838-43. PubMed ID: 18462108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridium difficile infection in older adults: a review and update on its management.
    Kee VR
    Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection.
    Hu MY; Katchar K; Kyne L; Maroo S; Tummala S; Dreisbach V; Xu H; Leffler DA; Kelly CP
    Gastroenterology; 2009 Apr; 136(4):1206-14. PubMed ID: 19162027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection.
    Brandt LJ; Aroniadis OC; Mellow M; Kanatzar A; Kelly C; Park T; Stollman N; Rohlke F; Surawicz C
    Am J Gastroenterol; 2012 Jul; 107(7):1079-87. PubMed ID: 22450732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunosuppressive treatment as a risk factor for the occurrence of clostridium difficile infection (CDI)].
    Lübbert C; Johann C; Kekulé AS; Worlitzsch D; Weis S; Mössner J; Behl S; Seufferlein T
    Z Gastroenterol; 2013 Nov; 51(11):1251-8. PubMed ID: 23696115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tigecycline for the treatment of severe Clostridium difficile infection.
    Larson KC; Belliveau PP; Spooner LM
    Ann Pharmacother; 2011 Jul; 45(7-8):1005-10. PubMed ID: 21730279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridium difficile infection: an update on epidemiology, risk factors, and therapeutic options.
    Lo Vecchio A; Zacur GM
    Curr Opin Gastroenterol; 2012 Jan; 28(1):1-9. PubMed ID: 22134217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of age on treatment outcomes in Clostridium difficile infection.
    Louie TJ; Miller MA; Crook DW; Lentnek A; Bernard L; High KP; Shue YK; Gorbach SL
    J Am Geriatr Soc; 2013 Feb; 61(2):222-30. PubMed ID: 23379974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clostridium difficile infection at a medical center in southern Taiwan: incidence, clinical features and prognosis.
    Chung CH; Wu CJ; Lee HC; Yan JJ; Chang CM; Lee NY; Chen PL; Lee CC; Hung YP; Ko WC
    J Microbiol Immunol Infect; 2010 Apr; 43(2):119-25. PubMed ID: 20457428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Epidemiology and Clinical Features of Clostridium difficile Infection in Liver Transplant Recipients.
    Sullivan T; Weinberg A; Rana M; Patel G; Huprikar S
    Transplantation; 2016 Sep; 100(9):1939-43. PubMed ID: 27379554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clostridium difficile infection in hospitalized patients at a Czech tertiary center: analysis of epidemiology, clinical features, and risk factors of fulminant course.
    Balihar K; Kozak F; Kozeluhova J; Hejda V; Fremundova L; Krcma M; Geigerova L; Bergerova T; Matejovic M
    Eur J Gastroenterol Hepatol; 2014 Aug; 26(8):880-7. PubMed ID: 24942955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection.
    Stevens V; Dumyati G; Fine LS; Fisher SG; van Wijngaarden E
    Clin Infect Dis; 2011 Jul; 53(1):42-8. PubMed ID: 21653301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.